These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3859929)

  • 61. High-dose cytosine arabinoside in the treatment of childhood malignancies.
    Lie SO; Slørdahl S
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):160-5. PubMed ID: 3859931
    [No Abstract]   [Full Text] [Related]  

  • 62. [Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia].
    Ohshima A; Yoshida K; Sato T; Miyazaki S; Yanagisawa M; Nakayama Y; Takahashi T; Mamiya S; Fukusima Y; Miura AB
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):192-5. PubMed ID: 3800405
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.
    Yates JW; Wallace HJ; Ellison RR; Holland JF
    Cancer Chemother Rep; 1973; 57(4):485-8. PubMed ID: 4586956
    [No Abstract]   [Full Text] [Related]  

  • 64. Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromes.
    Hoelzer D; Ganser A; Schneider W; Heimpel H
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):208-11. PubMed ID: 4012339
    [No Abstract]   [Full Text] [Related]  

  • 65. [Combination chemotherapy with cytosine arabinoside and daunomycin in childhood acute leukemia].
    Tsukimoto I; Mimaya J; Toyosaka H; Nagao T; Hanawa Y
    Rinsho Ketsueki; 1973 May; 14(5):596-603. PubMed ID: 4738276
    [No Abstract]   [Full Text] [Related]  

  • 66. [Treatment of leukemia with cytosine arabinoside--on the intensification of remission].
    Tatsumi N; Masaoka T; Ueda Y; Senda N
    Gan No Rinsho; 1970 Jul; 16(7):706-12. PubMed ID: 5465488
    [No Abstract]   [Full Text] [Related]  

  • 67. [Results of cytosine arabinoside treatment in adult patients with acute myeloblastic leukemia].
    Gepner-Woźniewska M; Retmańska A; Sobczynska-Czechowska Z; Pawelski S
    Acta Haematol Pol; 1973; 4(1):1-9. PubMed ID: 4522083
    [No Abstract]   [Full Text] [Related]  

  • 68. [Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, 6-mercaptopurine riboside and prednisolone].
    Hirano M; Morita A; Sako F; Uetani T; Koie K
    Rinsho Ketsueki; 1972 Dec; 13(6):951-7. PubMed ID: 4675066
    [No Abstract]   [Full Text] [Related]  

  • 69. [The effect of cytosine arabinoside on cell kinetics in adult acute leukemia and its correlation to the therapeutic response].
    Furusawa S; Adachi Y; Nomura T; Komiya M
    Rinsho Ketsueki; 1972 Dec; 13(6):943-50. PubMed ID: 4675065
    [No Abstract]   [Full Text] [Related]  

  • 70. Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia.
    Preisler HD; Raza A; Larson R; Browman G; Goldberg J; Grunwald H; Vogler R; Bennett J; Gottlieb A; D'Arrigo P
    Cancer Chemother Pharmacol; 1986; 18(3):257-60. PubMed ID: 3802381
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prediction of the response of patients with acute nonlymphocytic leukemia to cytosine arabinoside (NSC-63878) therapy.
    Burns CP; Armentrout SA; Stjernholm RL
    Cancer Chemother Rep; 1972 Aug; 56(4):527-34. PubMed ID: 4507687
    [No Abstract]   [Full Text] [Related]  

  • 72. Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia.
    Howard JP; Albo V; Newton WA
    Cancer; 1968 Mar; 21(3):341-5. PubMed ID: 5637945
    [No Abstract]   [Full Text] [Related]  

  • 73. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukaemia.
    Jensen MK; Ahlbom G
    Scand J Haematol; 1985 Mar; 34(3):261-3. PubMed ID: 3992192
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cytarabine.
    Med Lett Drugs Ther; 1971 Jan; 13(1):3-4. PubMed ID: 5284023
    [No Abstract]   [Full Text] [Related]  

  • 76. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
    Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
    Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Method of administration and inactivation of cytosine arabinoside in acute leukemia].
    Hirschmann WD; Kovacs EL; Gerecke D; Kaulen HD; Voigtmann R; Gross R
    Verh Dtsch Ges Inn Med; 1975; 81():1114-6. PubMed ID: 1229411
    [No Abstract]   [Full Text] [Related]  

  • 78. [Experiences with daunomycin and cytosine arabinoside in the therapy of acute myeloid leukemias].
    Kreiter H; Begemann H; Rastetter J
    Med Klin; 1968 Dec; 63(51):2058-66. PubMed ID: 5255517
    [No Abstract]   [Full Text] [Related]  

  • 79. Hypoplastic acute myeloid leukaemia with 7 years of complete remission by low-dose cytosine arabinoside therapy alone.
    Mori H; Fuchigami K; Nagai K; Kohno T; Maeda T; Nakamura H; Kuriyama K; Izumikawa K; Tomonaga M
    Eur J Haematol; 1995 Jul; 55(1):59-60. PubMed ID: 7615052
    [No Abstract]   [Full Text] [Related]  

  • 80. Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast.
    Satou Y; Kubota T; Yonekura S; Noguchi K; Oobayashi Y; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Oct; 11(4):249-54. PubMed ID: 3617109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.